Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) EVP Mary Ann E. Moore sold 8,108 shares of the business’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $16.00, for a total value of $129,728.00. Following the completion of the transaction, the executive vice president now directly owns 135,810 shares of the company’s stock, valued at approximately $2,172,960. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
Pediatrix Medical Group Stock Performance
Shares of MD stock traded down $0.46 during mid-day trading on Tuesday, reaching $15.50. The stock had a trading volume of 490,907 shares, compared to its average volume of 869,960. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $16.41. The company has a current ratio of 1.42, a quick ratio of 1.38 and a debt-to-equity ratio of 0.83. The firm has a market cap of $1.33 billion, a price-to-earnings ratio of -5.21, a PEG ratio of 2.26 and a beta of 1.55. The business’s fifty day moving average is $12.19 and its 200-day moving average is $9.69.
Pediatrix Medical Group (NYSE:MD – Get Free Report) last issued its quarterly earnings results on Friday, November 1st. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07. The company had revenue of $511.20 million for the quarter, compared to the consensus estimate of $498.87 million. Pediatrix Medical Group had a positive return on equity of 12.79% and a negative net margin of 12.65%. Pediatrix Medical Group’s revenue for the quarter was up .9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.29 earnings per share. On average, research analysts forecast that Pediatrix Medical Group, Inc. will post 1.25 earnings per share for the current year.
Hedge Funds Weigh In On Pediatrix Medical Group
Analyst Ratings Changes
MD has been the subject of several recent research reports. StockNews.com raised Pediatrix Medical Group from a “sell” rating to a “hold” rating in a research report on Wednesday, August 7th. Mizuho boosted their price target on Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Truist Financial upped their target price on Pediatrix Medical Group from $13.00 to $16.00 and gave the company a “hold” rating in a research report on Monday, November 4th. UBS Group upped their target price on Pediatrix Medical Group from $10.50 to $16.50 and gave the company a “neutral” rating in a research report on Tuesday, November 5th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on Pediatrix Medical Group from $9.00 to $15.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, Pediatrix Medical Group currently has a consensus rating of “Hold” and an average target price of $16.10.
Get Our Latest Stock Analysis on MD
About Pediatrix Medical Group
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Featured Articles
- Five stocks we like better than Pediatrix Medical Group
- Trading Halts Explained
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- What Makes a Stock a Good Dividend Stock?
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Energy and Oil Stocks Explained
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.